Product image

AIR-GRA 100mg 4's

(0)

Rs480

(In stock)

100 mg · Maximum Potency

AIR GRA 100 mg

Sildenafil Citrate Tablets · PDE5 Inhibito...

100 mg · Maximum Potency

AIR GRA 100 mg

Sildenafil Citrate Tablets · PDE5 Inhibitor · 4 Tablets

℞ Prescription Only Medicine

Product Overview

AIR GRA 100 mg is the maximum-strength Sildenafil Citrate tablet from Air Pharmaceuticals, delivering the full therapeutic potency of Sildenafil for the treatment of erectile dysfunction in adult men. It is the recommended step-up dose for patients who do not achieve a satisfactory response at 50 mg, and the preferred choice for severe organic, diabetic and vascular ED.

As a selective PDE5 inhibitor, AIR GRA 100 mg provides the highest efficacy ceiling in the range and resolves a majority of cases that were previously unresponsive to lower doses. The active ingredient is sourced from a US FDA registered manufacturer, assuring international-standard purity, potency and bioequivalence. For fastest and fullest effect, AIR GRA 100 mg is best taken on an empty stomach.

Key Features

  • Maximum licensed dose — highest efficacy ceiling in the Sildenafil range
  • Best for non-responders at 50 mg, severe organic, diabetic & vascular ED
  • Resolves 60–70% of patients who did not respond to lower doses
  • Onset: 30–60 minutes — fastest on an empty stomach
  • Duration: 4–6 hours of effective action
  • API from US FDA registered source — assured purity & bioequivalence

Specifications

Brand NameAIR GRA
Generic / ActiveSildenafil Citrate (equivalent to Sildenafil 100 mg)
Drug ClassPDE5 Inhibitor
IndicationErectile Dysfunction in adult men
Strength100 mg
Dosage FormFilm-coated tablet
Pack Size4 Tablets
Recommended DoseOne tablet 30–60 minutes before sexual activity, preferably fasted (max 1/day)
API SourceUS FDA Registered Manufacturer
StorageStore below 30°C, protect from light & moisture
Legal StatusPrescription Only Medicine (POM)
ManufacturerAir Pharmaceuticals (Pvt) Ltd., Kasur, Pakistan
View more

100 mg · Maximum Potency

AIR GRA 100 mg

Sildenafil Citrate Tablets · PDE5 Inhibitor · 4 Tablets

℞ Prescription Only Medicine

Product Overview

AIR GRA 100 mg is the maximum-strength Sildenafil Citrate tablet from Air Pharmaceuticals, delivering the full therapeutic potency of Sildenafil for the treatment of erectile dysfunction in adult men. It is the recommended step-up dose for patients who do not achieve a satisfactory response at 50 mg, and the preferred choice for severe organic, diabetic and vascular ED.

As a selective PDE5 inhibitor, AIR GRA 100 mg provides the highest efficacy ceiling in the range and resolves a majority of cases that were previously unresponsive to lower doses. The active ingredient is sourced from a US FDA registered manufacturer, assuring international-standard purity, potency and bioequivalence. For fastest and fullest effect, AIR GRA 100 mg is best taken on an empty stomach.

Key Features

  • Maximum licensed dose — highest efficacy ceiling in the Sildenafil range
  • Best for non-responders at 50 mg, severe organic, diabetic & vascular ED
  • Resolves 60–70% of patients who did not respond to lower doses
  • Onset: 30–60 minutes — fastest on an empty stomach
  • Duration: 4–6 hours of effective action
  • API from US FDA registered source — assured purity & bioequivalence

Specifications

Brand NameAIR GRA
Generic / ActiveSildenafil Citrate (equivalent to Sildenafil 100 mg)
Drug ClassPDE5 Inhibitor
IndicationErectile Dysfunction in adult men
Strength100 mg
Dosage FormFilm-coated tablet
Pack Size4 Tablets
Recommended DoseOne tablet 30–60 minutes before sexual activity, preferably fasted (max 1/day)
API SourceUS FDA Registered Manufacturer
StorageStore below 30°C, protect from light & moisture
Legal StatusPrescription Only Medicine (POM)
ManufacturerAir Pharmaceuticals (Pvt) Ltd., Kasur, Pakistan

Add your review

Your email address will not be published. Required fields are marked *

Please login to write review!

Upload photos

Looks like there are no reviews yet.

You may also like

Take it to your cart

Newsletter

Subscribe our newsletter

By clicking the button, you are agreeing with our Term & Conditions

Your experience on this site will be improved by allowing cookies Cookie Policy